![Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis - The Lancet Diabetes & Endocrinology Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/aca16f12-c98a-481d-b85b-7fd636dee931/gr1.gif)
Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis - The Lancet Diabetes & Endocrinology
Short- and long-term effects of a need-supportive physical activity intervention among patients with type 2 diabetes mellitus: A randomized controlled pilot trial | PLOS ONE
![Type 1 Diabetes Mellitus: Symptoms, Treatment, Causes, Medications, Definition, Pathophysiology — EZmed Type 1 Diabetes Mellitus: Symptoms, Treatment, Causes, Medications, Definition, Pathophysiology — EZmed](https://images.squarespace-cdn.com/content/v1/5e48489da899cd09424943db/635e7fe8-857c-40d5-996b-09e77ca0ba94/type-1-diabetes-complications-microvascular-macrovascular.jpeg)
Type 1 Diabetes Mellitus: Symptoms, Treatment, Causes, Medications, Definition, Pathophysiology — EZmed
SA Health - Diabetes is a complex condition where the body can't maintain healthy levels of glucose (sugar) in the blood, which can lead to long term and short term health complications.
![Intensive insulin for type 2 diabetes: the risk of causing harm - The Lancet Diabetes & Endocrinology Intensive insulin for type 2 diabetes: the risk of causing harm - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/2009246086/2032058106/gr1.jpg)
Intensive insulin for type 2 diabetes: the risk of causing harm - The Lancet Diabetes & Endocrinology
![Short-term blood sugar control in patients with diabetes has limited effect on risk of cardiovascular problems Short-term blood sugar control in patients with diabetes has limited effect on risk of cardiovascular problems](https://scx2.b-cdn.net/gfx/news/hires/2013/shorttermblo.jpg)
Short-term blood sugar control in patients with diabetes has limited effect on risk of cardiovascular problems
![A short-term follow-up of glycemic and body weight changes in diabetic patients who replaced dipeptidyl peptidase-4 inhibitors with the sodium-glucose cotransporter 2 inhibitor empagliflozin | Annals of Saudi Medicine A short-term follow-up of glycemic and body weight changes in diabetic patients who replaced dipeptidyl peptidase-4 inhibitors with the sodium-glucose cotransporter 2 inhibitor empagliflozin | Annals of Saudi Medicine](https://www.annsaudimed.net/cms/asset/b8ae976f-ddca-4840-a31e-e96f9fe2f1ad/0370-oa_ig.jpg)